author-photo

Dragos Budinski

11

Papers

346

Citations

Citation Trend

Filter By

Papers (8) Sort By

Journal Conference Others

Pitavastatin demonstrates long-term efficacy, safety and tolerability in elderly patients with primary hypercholesterolaemia or combined (mixed) dyslipidaemia.

2013 European Journal of Preventive Cardiology
Show All
- Source
- Cite
- Save
Citations (15)
Comparative efficacy of pitavastatin and simvastatin in high-risk patients: a randomized controlled trial

2011 Advances in Therapy
Show All
- Source
- Cite
- Save
Citations (29)
Comparative long-term efficacy and tolerability of pitavastatin 4 mg and atorvastatin 20–40 mg in patients with type 2 diabetes mellitus and combined (mixed) dyslipidaemia

2011 Diabetes, Obesity and Metabolism
Show All
- Source
- Cite
- Save
Citations (62)
MS389 PITAVASTATIN 4 mg SHOWS COMPARABLE LDL-CHOLESTEROL AND SUPERIOR TRIGLYCERIDE REDUCTION TO SIMVASTATIN 40 mg IN HIGH-RISK PRIMARY HYPERCHOLESTEROLEMIA OR COMBINED DYSLIPIDEMIA

2010 Atherosclerosis Supplements
Show All
- Source
- Cite
- Save
Citations (9)
Long-term treatment with pitavastatin is effective and well tolerated by patients with primary hypercholesterolemia or combined dyslipidemia

2010 Atherosclerosis
Show All
- Source
- Cite
- Save
Citations (46)
Corrigendum to “Long-term treatment with pitavastatin is effective and well tolerated by patients with primary hypercholesterolemia or combined dyslipidemia” [Atherosclerosis 210 (2010) 202–208]

2010 Atherosclerosis
Show All
- Source
- Cite
- Save
Citations (2)
Original article Comparison of pitavastatin with simvastatin in primary hypercholesterolaemia or combined dyslipidaemia

2009
Show All
- Source
- Cite
- Save
Citations (0)
Comparison of pitavastatin with simvastatin in primary hypercholesterolaemia or combined dyslipidaemia

2009 Current Medical Research and Opinion
Show All
- Source
- Cite
- Save
Citations (69)